Information Provided By:
Fly News Breaks for July 6, 2015
OMER
Jul 6, 2015 | 07:58 EDT
After Omeros' stock sank about 23% since June 22, Wedbush notes that on June 25 an article recommended selling Omeros' stock. The firm says that the article based its conclusion on financial parameters suited to a mature, profitable company, rather than one which just launched its first drug, as is the case with Omeros. Wedbush adds that if the selloff in the stock was caused by the article, it recommends buying the shares. It believes that Omeros' fundamentals haven't changed, while the company has potentially significant catalysts this year. Wedbush keeps an Outperform rating on Omeros.
News For OMER From the Last 2 Days
There are no results for your query OMER